Analgesic Activity of Acyl-Salicylic Acid Derivatives And In Silico Docking Study For Their Potency As Cyclooxygenase-2 Inhibitors
Downloads
A series of acyl salicylic acid derivatives were screened to investigate their analgesic activities and their potency as cyclooxygenase-2 (COX-2) inhibitors. Fourteen compounds (BS1–14) were assayed by acetic acid induced writhing test. Their ability for interaction with COX-2 was studied through a docking simulation at the COX-2 active site (PDB. 5IKQ). The results of the analgesic activity test gave 3 compounds that produce ED50< 0.39 mmol/kg body weight, lower than aspirin as a positive control. The compounds BS3 and BS4 showed excellent analgesic activity and the tert-butyl substituted molecule BS3 (O-(4-tert-butylbenzoyl)-salicylic acid analog) showed the highest analgesic activity with ED50 of 0.26 mmol/kg. Based on in silico molecular docking, it is known that almost all of the tested ligands (12 compounds) showed a higher binding affinity for COX-2 than meclofenamic acid which is a COX-2 inhibitory NSAID. The results of in vivo analgesic activity were justified with the outcome of in silico investigation. Molecular docking of acyl-salicylates confirmed in vivo experiments and it was found that BS3 was the most active compound as an analgesic agent and the most potent as a COX-2 inhibitor among the evaluated compounds.
a
Aronoff, D.M., Boutaud, O., Marnett, L.J., and Oates, J.A. (2003). Inhibition of Prostaglandin H2 Synthases by Salicylate is Dependent on the Oxidative State of the Enzymes. J Pharmacol Exp Ther, 304 (2), 589-595.
Amann, R., and Peskar, B.A. (2002). Review Anti-inflammatory effects of aspirin and sodium salicylate, Eur. J. Pharmacol., 447 (1), 1-9.
Bell, R., Harris, R.R., Stewart, A.O. (2003) COX-2 Inhibitors and Leucotriene Modulators. In: Abraham, D.J. (ed.) Burger’s Medicinal Chemistry and Drug Discovery 6th Vol. 4: Autocoids, Diagnostics, and Drugs from New Biology John Wiley and Sons, Inc. pp. 229 – 246.
Cieslik, K.A., Zhu, Y., Shtivelband, M., Wu, K.K. (2005). Inhibition of p90 Ribosomal S6 Kinase-mediated CCAAT/Enhancer binding Protein Activation and Cyclooxygenase-2 Expression by Salicylate., J. Biol. Chem., 280 (18), 18411–18417.
Cronstein, B.N., Montesinos, M.C., Weissmann, W. (1999), Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkB. Proc. Natl. Acad. Sci., 96, 6377-6381.
Diyah, N.W., Susilowati, R., Hardjono, S. (2010). Kinetics of Degradation of Benzoylsalicylic Acid Derivatives in an Alkaline Solution. Majalah Farmasi Airlangga, 8 (2), 31-35.
Diyah, N.W., Siswandono. (2014). Docking Molekul Dan Sintesis Turunan Asam Benzoil Salisilat Tersubstitusi Klor Sebagai Penghambat Siklooksigenase-2. Berkala Ilmiah Kimia Farmasi, 3 (1), 7–15.
Diyah, N.W., Nofianti, K.A., Hakim, L. (2016). Aktivitas Antiinflamasi Turunan Asam O-Benzoilsalisilat. Berkala Ilmiah Kimia Farmasi, 5 (1), 14 – 17.
de Arriba, A.F., Fernando Cavalcanti, F., Agustí Miralles, A., Yolanda Bayón, Y., Andrés Alonso, A., Merlos, M., García-Rafanell, J., Forn, (1999). Inhibition of Cyclooxygenase-2 Expression by 4Trifluoromethyl Derivatives of Salicylate, Triflusal, and Its Deacetylated Metabolite, 2-Hydroxy-4-trifluoromethylbenzoic Acid. J Mol. Pharmacol., 55 (4), 753-760.
Hinz, B., Kraus, V., Pahl, A., Brune, K. (2000). Salicylate Metabolites Inhibit Cyclooxygenase-2-Dependent Prostaglandin E2 Synthesis in Murine Macrophages. Biochem. Biophys. Res.Commun., 274 (1), 197 – 202.
Kosinski, P., Sarzynska-Nowacka, U., Fiolna, M., Wielgos, M. (2018). The practical use of acetylsalicylic acid in the era of the ASPRE trial. Update and literature review. Ginekol Pol. 2018, 89 (2), 107-111.
Law, B.K., Waltner-Lawi, M.E., Entingh, A.J., Chytil, A., Aakre, M.E., Nùrgaard, P., Moses, H.L. (2000). Salicylate-induced Growth Arrest is Associated with Inhibition of p70 s6k and Down-regulation of c-Myc, Cyclin D1, Cyclin A, and Proliferating Cell Nuclear Antigen. J. Biol. Chem., 275 (49), 38261-38267.
Miranda, H.F., Sierralta, F., Aranda, N., et al. (2016) Pharmacological profile of dexketoprofen in oofacial pain. Pharmacol Rep, 68, 1111–1114.
Mitchell, J.A., Saunders, M., Peter J., Barnes, P.J., Newton, R., Belvisi, M.G. (1997). Sodium Salicylate Inhibits Cyclo-Oxygenase-2 Activity Independently of Transcription Factor (Nuclear Factor κB) Activation: Role of Arachidonic Acid. Mol. Pharmacol., 51 (6), 907-912.
Noriega, V., Sierralta, F., Poblete, P., Aranda, N., Sotomayor-Zarate, R., Cprieto, J., Miranda, H. F. (2020). Receptors involved in dexketoprofen analgesia in murine visceral pain. J Biosci, (2020) 45 (94 ), 1–6
Orlando, B.J., Malkowski, M.G. (2016). Substrate-selective Inhibition of Cyclooxygenase-2 by Fenamic Acid Derivatives Is Dependent on Peroxide Tone. (2016) J Biol Chem 291: 15069-15081.
Saunders, M.A., Sansores-Garcia, L., Gilroy, D.W., Wu, K.K. (2001). Selective Suppression of CCAAT/Enhancer-binding Protein Binding and Cyclooxygenase-2 Promoter Activity by Sodium Salicylate in Quiescent Human Fibroblasts. J. Biol. Chem., 276 (22), 18897-18904.
Thomsen, R., Christensen, M.H. (2006). MolDock: a new technique for high-accuracy molecular docking. J Med Chem, 49(11), 3315-3321.
Wu, K. (2003). Aspirin and other cyclooxygenase inhibitors: new therapeutic insights. Semin Vasc Med, 3 (2), 107-12.
BIKF by Unair is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under “the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.
